You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 5, May 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE 91ST ANNUAL MEETING OF THE WESTERN SURGICAL ASSOCIATION, MONTEREY, CALIF, NOV 14-16, 1983-PART I
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Improved Treatment of the Stevens-Johnson Syndrome

Janet A. Marvin, RN, MN; David M. Heimbach, MD; Loren H. Engrav, MD; Timothy J. Harnar, MD

Arch Surg. 1984;119(5):601-605.


Abstract

• The Stevens-Johnson syndrome (SJS), a disease resulting in greater than 30% body surface area epidermal and mucosal desquamation, is reported to have a mortality of greater than 50%. Recommended treatment has included steroids, prophylactic antibiotics, nutritional support, and application of topical antibacterials. Since the lesions represent only epidermal loss without dermal necrosis, rapid reepithelialization should occur if the dermis is protected from desiccation with a biological dressing. Five nonburned patients with severe SJS were treated in the University of Washington burn center, Seattle, with urgent operative débridement of their wounds and application of porcine xenograft immediately after admission. Steroid administration was stopped. Antibiotics were used only for culture-proved infections. All patients completely reepithelialized within a mean of 18 days. There was one death, a 9-year-old boy who was completely reepithelialized when sudden fatal sepsis that originated from a ventriculovenous shunt placed when he was an infant developed. In this group of patients, rapid wound closure with xenograft and supportive care permitted rapid reepithelialization and decreased mortality and morbidity.

(Arch Surg 1984;119:601-605)



Author Affiliations

From the Department of Surgery (Drs Marvin, Heimbach, and Harnar) and Division of Plastic Surgery (Dr Engrav), University of Washington, Harborview Medical Center, Seattle.


Footnotes

Accepted for publication Jan 6, 1984.

Read before the 91st annual meeting of the Western Surgical Association, Monterey, Calif, Nov 16, 1983.

Reprint requests to Department of Surgery, ZA-16, Harborview Medical Center, 325 Ninth Ave, Seattle, WA 98104 (Dr Heimbach).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Case 34-2005 -- A 10-Year-Old Girl with a Bullous Skin Eruption and Acute Respiratory Failure.
Sheridan et al.
NEJM 2005;353:2057-2066.
FULL TEXT  

Management of Acquired Bullous Skin Diseases
Fine
NEJM 1995;333:1475-1484.
FULL TEXT  

A Comprehensive Approach: Multidisciplinary Management in a Burn Center
Taylor et al.
CLIN PEDIATR 1989;28:404-407.
ABSTRACT  

Treatment of Toxic Epidermal Necrolysis: Creteil's Experience
Revuz et al.
Arch Dermatol 1987;123:1156-1158.
ABSTRACT  

Toxic Epidermal Necrolysis: A Step Forward in Treatment
Heimbach et al.
JAMA 1987;257:2171-2175.
ABSTRACT  

Management of Toxic Epidermal Necrolysis in a Pediatric Burn Center
Adzick et al.
Arch Pediatr Adolesc Med 1985;139:499-502.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.